Siming Li

3.1k total citations · 1 hit paper
85 papers, 1.9k citations indexed

About

Siming Li is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Siming Li has authored 85 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 26 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Siming Li's work include Cancer Immunotherapy and Biomarkers (26 papers), Cutaneous Melanoma Detection and Management (23 papers) and CAR-T cell therapy research (17 papers). Siming Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (26 papers), Cutaneous Melanoma Detection and Management (23 papers) and CAR-T cell therapy research (17 papers). Siming Li collaborates with scholars based in China, United States and Ethiopia. Siming Li's co-authors include Xinan Sheng, Lu Si, Chuanliang Cui, Zhihong Chi, Bixia Tang, Jun Guo, Bin Lian, Yan Kong, Jiandie D. Lin and Lili Mao and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Annals of Neurology.

In The Last Decade

Siming Li

82 papers receiving 1.8k citations

Hit Papers

Hyperlipidemic Effects of Dietary Saturated Fats Mediated... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
    2005 513 citations Jiandie D. Lin, Ruojing Yang et al. Cell profile →

Peers

Siming Li
Maren Luchtefeld Germany
Jun Cai China
Samy L. Habib United States
Xiaoxin X. Wang United States
Fouad A. Zouein Lebanon
Maaike Kockx Australia
Xu Guan China
Hong Pei United States
Jelena Todoric Austria
Miguel Arévalo Spain
Maren Luchtefeld Germany
Siming Li
Citations per year, relative to Siming Li Siming Li (= 1×) peers Maren Luchtefeld

Countries citing papers authored by Siming Li

Since Specialization
Citations

This map shows the geographic impact of Siming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Li more than expected).

Fields of papers citing papers by Siming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Li. The network helps show where Siming Li may publish in the future.

Co-authorship network of co-authors of Siming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Siming Li. A scholar is included among the top collaborators of Siming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siming Li. Siming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Jingen, Yanhui Wang, Siming Li, et al.. (2024). Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): A randomized controlled trial. Journal of Evidence-Based Medicine. 17(3). 526–534. 4 indexed citations
3.
4.
Li, Yatong, Yang Chen, Siming Li, et al.. (2024). Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder. Movement Disorders. 39(7). 1179–1189. 1 indexed citations
5.
Mao, Lili, Jie Dai, Xue Bai, et al.. (2024). Neoadjuvant pembrolizumab and lenvatinib in resectable mucosal melanoma: NeoPlus study update.. Journal of Clinical Oncology. 42(16_suppl). 9580–9580. 2 indexed citations
6.
Liu, Teli, Siming Li, Xiaokun Ma, et al.. (2023). An iodine‑labelled Antibody–drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma. International Journal of Pharmaceutics. 651. 123756–123756. 12 indexed citations
7.
Li, Siming, Xiaowen Wu, Xieqiao Yan, et al.. (2022). Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis. Journal for ImmunoTherapy of Cancer. 10(2). e004036–e004036. 33 indexed citations
8.
9.
Wang, Yang, Bin Lian, Lu Si, et al.. (2022). Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I–III. European Journal of Cancer. 175. 196–203. 3 indexed citations
10.
Zhou, Li, Yiqiang Liu, Chuanliang Cui, et al.. (2022). Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma. Urologic Oncology Seminars and Original Investigations. 40(8). 385.e1–385.e8. 3 indexed citations
11.
Li, Siming, Wentao Xu, Yuanping Zhou, et al.. (2021). The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 23–33. 20 indexed citations
12.
Yan, Xieqiao, Xinan Sheng, Zhihong Chi, et al.. (2021). Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma. Journal of Clinical Oncology. 39(8). 881–889. 36 indexed citations
13.
Tang, Bixia, Xieqiao Yan, Rong Duan, et al.. (2021). Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma. European Journal of Cancer. 156. 83–92. 13 indexed citations
14.
Straker, Richard J., Yun Song, James Sun, et al.. (2020). Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era. Annals of Surgical Oncology. 28(7). 3512–3521. 10 indexed citations
15.
Chen, Zhuo, Xiang Gao, Yang Jiao, et al.. (2019). Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway. Frontiers in Pharmacology. 10. 850–850. 51 indexed citations
16.
Sheng, Xinan, Dengfeng Cao, Jianlin Yuan, et al.. (2018). Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. European Journal of Cancer. 100. 1–7. 37 indexed citations
17.
18.
Sheng, Xinan, Siming Li, Zhihong Chi, et al.. (2015). Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients. British Journal of Ophthalmology. 99(7). 990–996. 47 indexed citations
19.
Lian, Bin, Lu Si, Chuanliang Cui, et al.. (2013). Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma. Clinical Cancer Research. 19(16). 4488–4498. 121 indexed citations
20.
Lin, Jiandie D., Ruojing Yang, Paul T. Tarr, et al.. (2005). Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP. Cell. 120(2). 261–273. 513 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maren Luchtefeld Breakdown of academic impact, for papers by Jun Cai Breakdown of academic impact, for papers by Samy L. Habib Breakdown of academic impact, for papers by Xiaoxin X. Wang Breakdown of academic impact, for papers by Fouad A. Zouein Breakdown of academic impact, for papers by Maaike Kockx Breakdown of academic impact, for papers by Xu Guan Breakdown of academic impact, for papers by Hong Pei Breakdown of academic impact, for papers by Jelena Todoric Breakdown of academic impact, for papers by Miguel Arévalo
Rankless by CCL
2026